Follow-The-Filings

AXSM · Axsome Therapeutics Inc.

Q3 2023 13F holders

← latest ownership dossier

Ticker
AXSM
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares